UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Date of Report (Date of earliest event reported): April 30, 2014 (April 30, 2014)
AMSURG CORP.
(Exact Name of Registrant as Specified in its Charter)
Tennessee |
000-22217 |
62-1493316 |
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
|
|
|
20 Burton Hills Boulevard |
|
|
Nashville, Tennessee |
|
37215 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
(615) 665-1283
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure
On April 30, 2014, AmSurg Corp. issued a press release, the text of which is set forth as Exhibit 99.
Item 9.01. Financial Statements and Exhibits
(d) 99 Press release dated April 30, 2014
2
SIGNATURES |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. |
||||
|
|||||
|
|
|
|
|
|
|
|
|
|
AMSURG CORP. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Claire M. Gulmi |
|
|
|
|
|
Claire M. Gulmi |
|
|
|
|
|
|
|
|
|
|
|
Executive Vice President and |
|
|
|
|
|
Chief Financial Officer |
|
|
|
|
|
(Principal Financial and Duly Authorized Officer) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date: |
April 30, 2014 |
|
|
|
|
|
|
|
|
|
|
3
INDEX TO EXHIBITS
Exhibit |
|
|
Number |
|
Description |
99 |
|
Press release dated April 30, 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
Contact: |
Claire M. Gulmi |
|
|
Executive Vice President and |
|
|
Chief Financial Officer |
|
|
(615) 665-1283 |
AMSURG CORP. TO PRESENT AT THE
DEUTSCHE BANK 39TH ANNUAL HEALTH CARE CONFERENCE
NASHVILLE, Tenn. – (April 30, 2014) – AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the Deutsche Bank 39th Annual Health Care Conference on Wednesday, May 7, 2014, in Boston, Massachusetts. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company’s web site starting at 8:40 a.m. Eastern Time / 7:40 a.m. Central Time. Christopher A. Holden, President and Chief Executive Officer, and Claire M. Gulmi, Executive Vice President and Chief Financial Officer, will be speaking at the conference.
The live audio webcast and replay of the presentation will be available on the Company’s website by going to www.amsurg.com and clicking on Investors. For the live audio, please go to the site at least 15 minutes prior to the presentation to download and install any necessary audio software. The webcast replay will be available for 30 days.
AmSurg Corp. acquires, develops and operates ambulatory surgery centers in partnership with physician practice groups throughout the United States. At March 31, 2014, AmSurg owned and operated 242 centers.
- END –